PBYI

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Puma Biotechnology Inc

NASDAQ | PBYI

5.04

USD

$0.00

(

0.00%

)

At Close (As of Oct 23, 2025)

$263.44M

Market Cap

5.09

P/E Ratio

0.99

EPS

$6.07

52 Week High

$2.31

52 Week Low

HEALTHCARE

Sector

PBYI Chart

Recent Chart
Price Action

PBYI Technicals

Tags:

PBYI Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $166M
Total Revenue $230M
Cost Of Revenue $64M
Costof Goods And Services Sold $64M
Operating Income $31M
Selling General And Administrative $81M
Research And Development $55M
Operating Expenses $135M
Investment Income Net -
Net Interest Income -$7.7M
Interest Income $4.7M
Interest Expense $12M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $12M
Income Before Tax $24M
Income Tax Expense -$6.2M
Interest And Debt Expense -
Net Income From Continuing Operations $30M
Comprehensive Income Net Of Tax -
Ebit $37M
Ebitda $48M
Net Income $30M

Revenue & Profitability

Earnings Performance

PBYI Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $213M
Total Current Assets $148M
Cash And Cash Equivalents At Carrying Value $69M
Cash And Short Term Investments $69M
Inventory $8.7M
Current Net Receivables $32M
Total Non Current Assets $66M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $51M
Intangible Assets Excluding Goodwill $51M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $32M
Other Current Assets $6M
Other Non Current Assets -
Total Liabilities $121M
Total Current Liabilities $96M
Current Accounts Payable $5.5M
Deferred Revenue -
Current Debt -
Short Term Debt $56M
Total Non Current Liabilities $25M
Capital Lease Obligations $7M
Long Term Debt $22M
Current Long Term Debt $45M
Long Term Debt Noncurrent -
Short Long Term Debt Total $74M
Other Current Liabilities $34M
Other Non Current Liabilities $1.8M
Total Shareholder Equity $92M
Treasury Stock -
Retained Earnings -$1.3B
Common Stock $5K
Common Stock Shares Outstanding $49M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $39M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $12M
Capital Expenditures $56K
Change In Receivables -
Change In Inventory -$1.6M
Profit Loss -
Cashflow From Investment -$20M
Cashflow From Financing -$34M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $30M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $166M
Total Revenue $230M
Cost Of Revenue $64M
Costof Goods And Services Sold $64M
Operating Income $31M
Selling General And Administrative $81M
Research And Development $55M
Operating Expenses $135M
Investment Income Net -
Net Interest Income -$7.7M
Interest Income $4.7M
Interest Expense $12M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $12M
Income Before Tax $24M
Income Tax Expense -$6.2M
Interest And Debt Expense -
Net Income From Continuing Operations $30M
Comprehensive Income Net Of Tax -
Ebit $37M
Ebitda $48M
Net Income $30M

PBYI News

PBYI Profile

Puma Biotechnology Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Puma Biotechnology, Inc. is a biopharmaceutical firm based in Los Angeles that specializes in the development and commercialization of innovative cancer therapies aimed at enhancing treatment outcomes for patients globally. With a strong emphasis on precision medicine, Puma is advancing a proprietary pipeline of drug candidates targeting specific oncological indications, addressing crucial unmet needs in the oncology sector. The company's strategic positioning and commitment to innovation make it a significant player in the rapidly evolving cancer therapeutics market, presenting an appealing investment opportunity for institutional investors looking to capitalize on breakthroughs in this critical area of healthcare.

YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
INTC
+3.35%
$38.15
BURU
-5.27%
$0.34
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.63%
$24.62
ADAP
-3.44%
$0.07
MSAI
+101.73%
$1.35
AAL
+5.62%
$12.77
BITF
+5.71%
$4.16
VIVK
+5.68%
$0.26
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
DNN
+0.36%
$2.73
IONQ
+7.06%
$59.37
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
SMCI
-8.72%
$47.92
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
RGTZ
-20.27%
$14.90
GRAB
+1.77%
$5.72
SOFI
+3.27%
$28.08
RBNE
+7.87%
$1.37
BBD
+1.51%
$3.35
JOBY
+1.29%
$15.67
RF
-0.04%
$24.10
WGRX
+9.03%
$0.40
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.46%
$10.91
QS
+7.95%
$14.66
SGBX
+29.82%
$2.96
RMBL
+60.50%
$3.21
AMD
+2.06%
$234.99
BTG
+0.38%
$5.23
ADD
-25.47%
$0.05
VLY
+4.24%
$10.56
ONDS
+4.74%
$7.06
GPUS
-0.28%
$0.38
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
CIFR
+7.10%
$17.25
PFE
-0.20%
$24.67
TNGX
-13.04%
$7.53
UUUU
-6.50%
$21.26
BTBT
+3.62%
$3.72
AAPL
+0.43%
$259.58
MARA
+0.36%
$19.22
AMC
-0.72%
$2.73
DVLT
+5.14%
$2.25
WBD
+3.50%
$21.25
AMZN
+1.44%
$221.09
IREN
+7.77%
$55.86
HPE
+0.43%
$23.19
PBR
+0.93%
$11.84
NIO
+0.73%
$6.89
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
NVTS
+0.03%
$13.61
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
SCWO
+32.07%
$0.48
LUV
-6.25%
$31.65
RR
+7.11%
$5.42
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SNAP
+1.28%
$7.87
BAC
+1.29%
$51.76
RIVN
+1.31%
$13.09
BTE
+5.72%
$2.40
APLD
+9.01%
$33.38
VALE
-0.52%
$11.46
HOOD
+5.58%
$134.33
DNUT
+1.98%
$4.11
LUMN
+10.65%
$7.79
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
CLSK
+4.80%
$17.67
NAKA
+10.41%
$0.79
KDLY
+10.41%
$0.79
YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
INTC
+3.35%
$38.15
BURU
-5.27%
$0.34
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.63%
$24.62
ADAP
-3.44%
$0.07
MSAI
+101.73%
$1.35
AAL
+5.62%
$12.77
BITF
+5.71%
$4.16
VIVK
+5.68%
$0.26
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
DNN
+0.36%
$2.73
IONQ
+7.06%
$59.37
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
SMCI
-8.72%
$47.92
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
RGTZ
-20.27%
$14.90
GRAB
+1.77%
$5.72
SOFI
+3.27%
$28.08
RBNE
+7.87%
$1.37
BBD
+1.51%
$3.35
JOBY
+1.29%
$15.67
RF
-0.04%
$24.10
WGRX
+9.03%
$0.40
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.46%
$10.91
QS
+7.95%
$14.66
SGBX
+29.82%
$2.96
RMBL
+60.50%
$3.21
AMD
+2.06%
$234.99
BTG
+0.38%
$5.23
ADD
-25.47%
$0.05
VLY
+4.24%
$10.56
ONDS
+4.74%
$7.06
GPUS
-0.28%
$0.38
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
CIFR
+7.10%
$17.25
PFE
-0.20%
$24.67
TNGX
-13.04%
$7.53
UUUU
-6.50%
$21.26
BTBT
+3.62%
$3.72
AAPL
+0.43%
$259.58
MARA
+0.36%
$19.22
AMC
-0.72%
$2.73
DVLT
+5.14%
$2.25
WBD
+3.50%
$21.25
AMZN
+1.44%
$221.09
IREN
+7.77%
$55.86
HPE
+0.43%
$23.19
PBR
+0.93%
$11.84
NIO
+0.73%
$6.89
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
NVTS
+0.03%
$13.61
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
SCWO
+32.07%
$0.48
LUV
-6.25%
$31.65
RR
+7.11%
$5.42
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SNAP
+1.28%
$7.87
BAC
+1.29%
$51.76
RIVN
+1.31%
$13.09
BTE
+5.72%
$2.40
APLD
+9.01%
$33.38
VALE
-0.52%
$11.46
HOOD
+5.58%
$134.33
DNUT
+1.98%
$4.11
LUMN
+10.65%
$7.79
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
CLSK
+4.80%
$17.67
NAKA
+10.41%
$0.79
KDLY
+10.41%
$0.79
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.